British Patient Capital was founded to boost long-term funding for U.K. technology companies from Series B and beyond. An independent evaluation suggests it is having an impact on growth, jobs and valuations
British Patient Capital was founded to boost long-term funding for U.K. technology companies from Series B and beyond. An independent evaluation suggests it is having an impact on growth, jobs and valuations